olanzapine vs. clozapine
PreclinicalSmall molecule
olanzapine vs. clozapine is one of 57 small molecule programs targeting Schizoaffective Disorder. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
56
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
66 competitors in Schizoaffective Disorder
#DrugCompanyPhaseTrials
1Risperdal
WWim Janssens
Approved
Zyprexa
MMODAG GmbH
Approved
Nicorette
PfizerApproved
Depakote
TevaApproved
Seroquel
EEngelhard Arzneimittel GmbH & Co.KG
Approved
Abilify
OtsukaApproved
Diamox
TevaApproved
Estrace
Novo NordiskApproved
Nuvigil
NNuvo Research GmbH
Approved
Pravachol
KKaruna Therapeutics, Inc., a Bristol Myers Squibb company
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for olanzapine vs. clozapine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- VVanderbilt University